Regenerative medicine

Contents

Terms of reference

Summary

1 Introduction

Our inquiry

2 Research and commercialisation

The research landscape

Basic and translational research

Commercialisation

Regulation

Opportunities for manufacturing

3 Adoption in the NHS

NHS infrastructure

NICE Heath Technology Appraisals and NHS Specialised Commissioning

Payment and reimbursement

A strategy for regenerative medicine

Conclusions and recommendations

Annex: Visit to UCL and Centre for Cell Gene and Tissue Therapeutics, Royal Free Hospital

Glossary of terms/abbreviations used in report

Formal Minutes

Witnesses

Published written evidence

List of Reports from the Committee during the current Parliament





28 April 2017